ARMATA PHARMACEUTICALS INCARMP
ASignal's systematic analysis rates ARMP as Bearish.
Reflects the latest available analysis · analyzed Oct 18, 2026
The case on ARMP
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Revenue growth of 15.7% indicates moderate-to-high growth trajectory
- Growth score of 0.7 suggests strong forward-looking revenue expansion potential
- RSI near 43 indicates neutral-to-slightly bullish positioning, not overbought
- Negative operating and gross margins (-410.84% and -217.36%) reflect severe profitability challenges
- Negative free cash flow of $-27.41M and negative operating cash flow of $-25.42M signal financial strain
- Current ratio and quick ratio both at 0.11x indicate critical liquidity risk
- High EV/Revenue of 74.92x and negative EV/EBITDA suggest extreme valuation concerns
- Total debt of $313.95M significantly exceeds cash of $23.95M, raising solvency risks
- MACD below signal line with negative histogram indicates ongoing downtrend
See the full verdict on ARMP
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ARMP
Most investors never get a second opinion, let alone several. ASignal runs ARMP past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.